Latest News and Press Releases
Want to stay updated on the latest news?
-
Prescription Drug User Fee Act (PDUFA) target action date set for September 28, 2026If approved, Ameluz® would be the first and only PDT photosensitizer indicated for the treatment of superficial...
-
Dublin, Feb. 05, 2026 (GLOBE NEWSWIRE) -- The "Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's...
-
Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Photoimmunotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's...
-
LOUISVILLE, K.Y., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Sun Pharmaceuticals for...
-
Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer (NSCLC) Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering. The...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Nectin-4-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
-
Dublin, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The "PD-1 Resistant Head and Neck Cancer - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
-
Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Head and Neck Squamous Cell Carcinoma Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast,...
-
Austin, TX, USA, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “NUT Midline Carcinoma Treatment Market Size, Trends and Insights By Treatment...
-
Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...